Ignite Creation Date:
2024-05-06 @ 7:47 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06135233
Status:
COMPLETED
Last Update Posted:
2023-11-18
First Post:
2023-11-13
Brief Title:
Implementation and Outcome of Minimally Invasive Pancreatoduodenectomy in Europe
Sponsor:
Academisch Medisch Centrum - Universiteit van Amsterdam AMC-UvA
Organization:
Academisch Medisch Centrum - Universiteit van Amsterdam AMC-UvA
Study Overview
Official Title:
Implementation and Outcome of Minimally Invasive Pancreatoduodenectomy in Europe A Critical Appraisal of the First 3 Years of the E-MIPS Registry
Status:
COMPLETED
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
E-MIPS
Brief Summary:
A planned analysis of outcomes among consecutive patients after MIPD from centers participating in the E-MIPS registry 2019-2021 Main outcomes of interest were major morbidity Clavien-Dindo grade 3 and 30-dayin-hospital mortality
Detailed Description:
The European registry for Minimally Invasive Pancreatic Surgery E-MIPS is an E-AHPBA endorsed registry with the aim to monitor and safeguard the introduction of MIPD in Europe International multicenter audit-based studies focusing on outcomes of minimally invasive pancreatoduodenectomy MIPD are lacking
A planned analysis of outcomes among consecutive patients after MIPD from centers participating in the E-MIPS registry 2019-2021 Main outcomes of interest were major morbidity Clavien-Dindo grade 3 and 30-dayin-hospital mortality
A planned analysis of outcomes among consecutive patients after MIPD from centers participating in the E-MIPS registry 2019-2021 Main outcomes of interest were major morbidity Clavien-Dindo grade 3 and 30-dayin-hospital mortality
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None